These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 2004317)

  • 1. Second cancers following non-Hodgkin's lymphoma.
    Travis LB; Curtis RE; Boice JD; Hankey BF; Fraumeni JF
    Cancer; 1991 Apr; 67(7):2002-9. PubMed ID: 2004317
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Second cancers among long-term survivors of non-Hodgkin's lymphoma.
    Travis LB; Curtis RE; Glimelius B; Holowaty E; Van Leeuwen FE; Lynch CF; Adami J; Gospodarowicz M; Wacholder S; Inskip P
    J Natl Cancer Inst; 1993 Dec; 85(23):1932-7. PubMed ID: 8230284
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk of leukemia following treatment for non-Hodgkin's lymphoma.
    Travis LB; Curtis RE; Stovall M; Holowaty EJ; van Leeuwen FE; Glimelius B; Lynch CF; Hagenbeek A; Li CY; Banks PM
    J Natl Cancer Inst; 1994 Oct; 86(19):1450-7. PubMed ID: 8089863
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased risk of lung cancer, non-Hodgkin's lymphoma, and leukemia following Hodgkin's disease.
    van Leeuwen FE; Somers R; Taal BG; van Heerde P; Coster B; Dozeman T; Huisman SJ; Hart AA
    J Clin Oncol; 1989 Aug; 7(8):1046-58. PubMed ID: 2754447
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk of second malignant neoplasms among long-term survivors of testicular cancer.
    Travis LB; Curtis RE; Storm H; Hall P; Holowaty E; Van Leeuwen FE; Kohler BA; Pukkala E; Lynch CF; Andersson M; Bergfeldt K; Clarke EA; Wiklund T; Stoter G; Gospodarowicz M; Sturgeon J; Fraumeni JF; Boice JD
    J Natl Cancer Inst; 1997 Oct; 89(19):1429-39. PubMed ID: 9326912
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Second cancer following lymphatic and hematopoietic cancers in Connecticut, 1935-82.
    Greene MH; Wilson J
    Natl Cancer Inst Monogr; 1985 Dec; 68():191-217. PubMed ID: 4088298
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Second malignancies following testicular cancer, ovarian cancer and Hodgkin's disease: an international collaborative study among cancer registries.
    Kaldor JM; Day NE; Band P; Choi NW; Clarke EA; Coleman MP; Hakama M; Koch M; Langmark F; Neal FE
    Int J Cancer; 1987 May; 39(5):571-85. PubMed ID: 3570550
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Second neoplasms in patients with Hodgkin's disease following combined modality therapy--the Yale experience.
    Koletsky AJ; Bertino JR; Farber LR; Prosnitz LR; Kapp DS; Fischer D; Portlock CS
    J Clin Oncol; 1986 Mar; 4(3):311-7. PubMed ID: 3950674
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Second cancers in patients with chronic lymphocytic leukemia.
    Travis LB; Curtis RE; Hankey BF; Fraumeni JF
    J Natl Cancer Inst; 1992 Sep; 84(18):1422-7. PubMed ID: 1512794
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Second malignancies following treatment in non-Hodgkin's lymphoma.
    Ellis M; Lishner M
    Leuk Lymphoma; 1993 Mar; 9(4-5):337-42. PubMed ID: 8348069
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Leukemia following low-dose total body irradiation and chemotherapy for non-Hodgkin's lymphoma.
    Travis LB; Weeks J; Curtis RE; Chaffey JT; Stovall M; Banks PM; Boice JD
    J Clin Oncol; 1996 Feb; 14(2):565-71. PubMed ID: 8636772
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Incidence of post transplant myelodysplasia/acute leukemia in non-Hodgkin's lymphoma patients compared with Hodgkin's disease patients undergoing autologous transplantation following cyclophosphamide, carmustine, and etoposide (CBV).
    Wheeler C; Khurshid A; Ibrahim J; Elias A; Mauch P; Ault K; Antin J
    Leuk Lymphoma; 2001 Feb; 40(5-6):499-509. PubMed ID: 11426523
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The risk of secondary malignancies over 30 years after the treatment of non-Hodgkin lymphoma.
    Tward JD; Wendland MM; Shrieve DC; Szabo A; Gaffney DK
    Cancer; 2006 Jul; 107(1):108-15. PubMed ID: 16708354
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantitative risk of second cancer in patients in first complete remission from early stages of Hodgkin's disease.
    Henry-Amar M
    NCI Monogr; 1988; (6):65-72. PubMed ID: 3352791
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact on second malignancy risk of the combined use of radiation and chemotherapy for lymphomas.
    Lavey RS; Eby NL; Prosnitz LR
    Cancer; 1990 Jul; 66(1):80-8. PubMed ID: 2354413
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Second primary malignancies in lymphoma patients.
    Takenaka T; Konda C; Sakano T; Shimoyama M; Kitahara T; Minato K; Watanabe S
    Jpn J Clin Oncol; 1985 Jun; 15(2):443-9. PubMed ID: 4021122
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Second neoplasms in Hodgkin's disease: current controversies.
    Zarrabi MH; Rosner F
    Hematol Oncol Clin North Am; 1989 Jun; 3(2):303-18. PubMed ID: 2663829
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Second cancer after the treatment for Hodgkin's disease: a report from the International Database on Hodgkin's Disease.
    Henry-Amar M
    Ann Oncol; 1992 Sep; 3 Suppl 4():117-28. PubMed ID: 1450072
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Secondary malignancies after treatment for indolent non-Hodgkin's lymphoma: a 16-year follow-up study.
    Sacchi S; Marcheselli L; Bari A; Marcheselli R; Pozzi S; Luminari S; Lombardo M; Buda G; Lazzaro A; Gobbi PG; Stelitano C; Morabito F; Quarta G; Brugiatelli M
    Haematologica; 2008 Mar; 93(3):398-404. PubMed ID: 18268277
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Second cancer following lymphatic and hematopoietic cancers in Denmark, 1943-80.
    Storm HH; Prener A
    Natl Cancer Inst Monogr; 1985 Dec; 68():389-409. PubMed ID: 4088311
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.